Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

RGEN

+ Watchlist+ Portfolio

Repligen Corp.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$172.67
52-Week Range
$100.99 – $198.87
Market Cap
$10.89B
P/E (TTM)
—
EPS (TTM)
-0.21
Dividend Yield
0.00%
Advanced Metrics
Price/Book
4.62
PEG Ratio
1.67
Return on Equity
-0.56%
Return on Assets
1.40%
Gross Margin
53.76%
Operating Margin
8.14%
Profit Margin
-1.47%
Current Ratio
9.88
Debt/Equity
0.33
Total Debt
$692.24M
Free Cash Flow
$111.58M
Revenue Growth
10.90%
Earnings Growth
—
Enterprise Value
$10.87B

Market Snapshot

About

Repligen Corporation is a life sciences company providing bioprocessing equipment and consumables for the biopharmaceutical industry. Repligen manufactures filtration systems, chromatography products, process analytics, and proteins used in the production of biologics and cell and gene therapies. The company serves biomanufacturers worldwide with products critical to drug development and commercial production.